Growth Metrics

Dexcom (DXCM) Long-Term Deferred Tax (2020 - 2025)

Dexcom (DXCM) has disclosed Long-Term Deferred Tax for 6 consecutive years, with $295.6 million as the latest value for Q4 2025.

  • Quarterly Long-Term Deferred Tax fell 38.57% to $295.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $295.6 million through Dec 2025, down 38.57% year-over-year, with the annual reading at $295.6 million for FY2025, 38.57% down from the prior year.
  • Long-Term Deferred Tax for Q4 2025 was $295.6 million at Dexcom, down from $375.6 million in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $501.3 million in Q3 2023, with the low at $216.3 million in Q3 2021.
  • Average Long-Term Deferred Tax over 5 years is $373.5 million, with a median of $362.3 million recorded in 2023.
  • The sharpest move saw Long-Term Deferred Tax surged 58.25% in 2022, then plummeted 38.57% in 2025.
  • Over 5 years, Long-Term Deferred Tax stood at $290.5 million in 2021, then increased by 17.45% to $341.2 million in 2022, then rose by 22.92% to $419.4 million in 2023, then increased by 14.74% to $481.2 million in 2024, then tumbled by 38.57% to $295.6 million in 2025.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods came in at $295.6 million, $375.6 million, and $496.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.